BOCA RATON, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and nononcological conditions, announces that management will hold a conference call on Thursday, August 8, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the second quarter of 2024. In addition, management will provide a business update and a discussion on recent and upcoming milestones. Parti ...

Zacks Consensus Estimate Earnings Whisper For Sensus Healthcare, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +20%. So, this combination indicates that Sensus Healthcare will most likely beat the consensus EPS estimate. While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past con ...

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done. Often, the direction of a stock's price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it's important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate re ...

Sensus Healthcare, Inc. (SRTS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. Thes ...

Often, the direction of a stock's price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it's important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate revisions, etc. -- that could keep the momentum in the stock going. Sensus Healthcare, Inc. (SRTS) is one of the several suitable candidates that passed through the screen. Here are the key reasons why it could be a profitable bet for "trend" inves ...

Analysts and investors alike will be keeping a close eye on the performance of Sensus Healthcare, Inc. in its upcoming earnings disclosure. In that report, analysts expect Sensus Healthcare, Inc. to post earnings of $0.02 per share. This would mark year-over-year growth of 200%. In the meantime, our current consensus estimate forecasts the revenue to be $6.87 million, indicating a 51.66% growth compared to the corresponding quarter of the prior year. The most recent trading session ended with Sensus Healthc ...

Sensus Healthcare, Inc. (SRTS) ended the recent trading session at $5.48, demonstrating a -0.54% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 0.26%. Elsewhere, the Dow saw an upswing of 0.18%, while the tech-heavy Nasdaq appreciated by 0.35%. Analysts and investors alike will be keeping a close eye on the performance of Sensus Healthcare, Inc. in its upcoming earnings disclosure. The company is expected to report EPS of $0.02, up 200% from the ...

Sensus Healthcare, Inc. (SRTS) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, SRTS crossed above the 20-day moving average, suggesting a short-term bullish trend. The 20-day simple moving average is a popular investing tool. Traders like this SMA because it offers a look back at a stock's price over a shorter period and helps smooth out price fluctuations. The 20-day can also show more trend reversal signals than longer-term moving ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Sensus Healthcare, Inc. (SRTS) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question. Sensus Healthcare, Inc. is a member of our Medical group, which includes 1046 different companies and currently sits at #7 in the Zacks Sector Rank. The Zacks Sector Rank ...

Company Participants Operator Thank you. This is Kim Golodetz with LHA. Thank you all for participating in today's call. Joining me from Sensus Healthcare are Joe Sardano, Chairman and Chief Executive Officer; Michael Sardano, President and General Counsel; and Javier Rampolla, Chief Financial Officer. Thank you, Kim, and good afternoon, everyone. We shipped 26 systems during the quarter compared with 10 a year ago when inflation and macroeconomic uncertainty had pronounced effect on our customers' business ...